Cite

    Lefebvre, P. et al. (n.d.). Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin—an electronic health-record-based study. Current medical research and opinion. pp. 1151-1159. [Online].